The Impact of Obesity on Diabetes Onset and Neovascularization in Mouse Models of Metabolic Stress
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25021214 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Sai Pranathi Meda Venkata und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, 259 Mack Ave, 3122 Applebaum Building, Detroit, MI 4…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Hyperglycemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Animal models of metabolic disorders are essential to studying pathogenic mechanisms and developing therapies for diabetes, but the induction protocols vary, and sexual dimorphism often exists. In a chronic diabetic model of diet-induced obesity (DIO) and low-dose streptozotocin (STZ)-induced hyperglycemia, blood glucose and lipid profiles were measured. The high-fat (HF) diet damaged insulin sensitivity and increased triglycerides, total cholesterol, LDL-cholesterol, HDL-cholesterol, and liver lipid deposition. STZ increased blood glucose and liver fibrosis with less effects on blood lipids or liver lipid deposition. The combination of DIO and STZ treatments led to significant liver lipid deposition and fibrosis. Female mice showed delayed body weight gain on HF diet and resisted STZ-induced hyperglycemia. However, once they developed DIO, which occurs around 26 weeks of HF diet, the female mice were prone to STZ-induced hyperglycemia. In hindlimb ischemia, male mice in the DIO-STZ group showed significantly worse neovascularization compared with DIO or STZ groups. The DIO-STZ females showed significantly worse recovery than the DIO-STZ males. Our observations suggest that DIO-STZ is a plausible model for studying metabolic and cardiovascular disorders in obesity and diabetes. Moreover, the findings in female animals stress the need to assess sexual dimorphism and investigate the underlying mechanisms that contribute to the worse vasculopathy manifestations in females in metabolic models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, 259 Mack Ave, 3122 Applebaum Building, Detroit, MI 48201, USA.
- Centers for Molecular Medicine and Genetics, Wayne State University, Detroit, MI 48201, USA.
- Karmanos Cancer Institute, Detroit, MI 48201, USA.
ORCID-Profile: Sai Pranathi Meda Venkata, Hainan Li, Jie-Mei Wang
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Zitieren
APA
Meda Venkata, S. P., Li, H., Xu, L., & Wang, J. M. (2024). The Impact of Obesity on Diabetes Onset and Neovascularization in Mouse Models of Metabolic Stress. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25021214
Vancouver
Meda Venkata SP, Li H, Xu L, Wang JM. The Impact of Obesity on Diabetes Onset and Neovascularization in Mouse Models of Metabolic Stress. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25021214
BibTeX
@article{MedaVenkata2024,
author = {Meda Venkata, Sai Pranathi and Li, Hainan and Xu, Liping and Wang, Jie-Mei},
title = {The Impact of Obesity on Diabetes Onset and Neovascularization in Mouse Models of Metabolic Stress},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25021214}
}
EUVIMED